HEAD AND NECK CANCER
Clinical trials for HEAD AND NECK CANCER explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCER trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human test of experimental cancer drug halted early
Disease control TerminatedThis was an early-stage study testing a new drug called BDC-3042, both by itself and combined with an existing immunotherapy (cemiplimab), in people with advanced cancers that had stopped responding to standard treatments. The main goals were to find safe doses and see if the tre…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE1 • Sponsor: Bolt Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Could fewer doctor visits be safer for cancer survivors?
Disease control TerminatedThis study aims to find the best way to monitor patients after successful head and neck cancer treatment. It compares the standard schedule of frequent scans and check-ups to a more personalized plan with fewer scheduled visits, focusing instead on tracking patient-reported sympt…
Matched conditions: HEAD AND NECK CANCER
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Targeted drug tested for tough cancers with rare genetic flaw
Disease control TerminatedThis study tested whether the drug niraparib could help control advanced solid tumors in patients whose cancer has a specific genetic change called a PALB2 mutation. It involved 22 adults with various cancers (like breast, lung, or pancreatic) that had spread or were locally adva…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: Tempus AI • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug tested to stop aggressive head & neck cancer from coming back
Disease control TerminatedThis study tested whether adding an experimental drug called xevinapant to standard radiotherapy could better prevent cancer from returning in people with high-risk head and neck cancer who had surgery. It focused on patients who could not safely take the usual high-dose chemothe…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE3 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Two-Pronged attack tested for tough cancers
Disease control TerminatedThis study tested whether combining two drugs, niraparib and dostarlimab, could help control advanced cancers that had specific genetic problems or were previously sensitive to platinum chemotherapy. It involved 51 adults with various cancers, including bladder, stomach, and kidn…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Experimental drug tested alongside standard cancer treatment
Disease control TerminatedThis early-stage study tested whether adding an experimental drug called xevinapant to standard chemotherapy and radiation was safe for people with advanced head and neck cancer. The trial enrolled 18 participants who had not received prior treatment for their cancer. Researchers…
Matched conditions: HEAD AND NECK CANCER
Phase: PHASE1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Quit smoking before surgery? new program aims to cut complications
Prevention TerminatedThis study tested if a 4-week stop-smoking program before major surgery could reduce complications after the operation. It involved 251 adult smokers scheduled for cancer or other major surgeries. The goal was to see if the structured quitting program led to fewer health problems…
Matched conditions: HEAD AND NECK CANCER
Phase: NA • Sponsor: Luzerner Kantonsspital • Aim: Prevention
Last updated Mar 24, 2026 12:02 UTC
-
Could a weekly dental clean stop cancer Patients' agonizing mouth sores?
Symptom relief TerminatedThis study tested whether a special weekly dental cleaning and gum treatment could reduce severe mouth sores in people receiving radiation or chemotherapy for head and neck cancer. About 60 participants were randomly assigned to receive either this special cleaning protocol or st…
Matched conditions: HEAD AND NECK CANCER
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC
-
App aims to ease depression for cancer survivors, but study stops early
Symptom relief TerminatedThis study aimed to test a smartphone app designed to help head and neck cancer survivors manage symptoms of depression. Participants were asked to use the mental health app for six weeks and complete surveys. The study was terminated early after enrolling only one person, so its…
Matched conditions: HEAD AND NECK CANCER
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Mar 24, 2026 12:02 UTC